Terms: = Breast cancer AND PR, PGR, progesterone receptor
15058 results:
1. Isolation and Characterization of a Novel Mammary Adenocarcinoma, MCa-P1362, with Hormone receptor Expression, Human Epidermal Growth Factor receptor 2 Positivity, and Enrichment in cancer and Mesenchymal Stem Cells.
Jana S; Li W; Lei PJ; Wang Z; Kibara S; Huang P; Jones D
Am J Pathol; 2024 Jun; 194(6):1137-1153. PubMed ID: 38749609
[TBL] [Abstract] [Full Text] [Related]
2. Axillary lymph node metastasis in pure mucinous carcinoma of breast: clinicopathologic and ultrasonographic features.
Li N; Li JW; Qian Y; Liu YJ; Qi XZ; Chen YL; Gao Y; Chang C
BMC Med Imaging; 2024 May; 24(1):108. PubMed ID: 38745134
[TBL] [Abstract] [Full Text] [Related]
3. Expression of p16 protein in breast cancer.
Samman A; Hanbazazh M; Samargandy S; Al-Maghrabi J
Pol J Pathol; 2024; 75(1):19-24. PubMed ID: 38741426
[TBL] [Abstract] [Full Text] [Related]
4. Clinicopathological Significance of Cyclin-Dependent Kinase 2 (CDK2) in Ductal Carcinoma In Situ and Early-Stage Invasive breast cancers.
Lashen A; Alqahtani S; Shoqafi A; Algethami M; Jeyapalan JN; Mongan NP; Rakha EA; Madhusudan S
Int J Mol Sci; 2024 May; 25(9):. PubMed ID: 38732271
[TBL] [Abstract] [Full Text] [Related]
5. The role of clinical breast examination and fine needle aspiration cytology in early detection of breast cancer: A cross-sectional study nested in a cohort in a low-resource setting.
Mremi A; Pallangyo A; Mshana T; Mashauri O; Kimario W; Nkya G; Mwakyembe TE; Mollel E; Amsi P; Mmbaga BT
Womens Health (Lond); 2024; 20():17455057241250131. PubMed ID: 38725253
[TBL] [Abstract] [Full Text] [Related]
6. Association between pathologic complete response and biochemical indicators after neoadjuvant therapy for HER2-positive breast cancer.
Chen W; Zhang J; Li F; Chen Z; Li J; Lu DL
World J Surg Oncol; 2024 May; 22(1):126. PubMed ID: 38725003
[TBL] [Abstract] [Full Text] [Related]
7.
Zang Z; Yin Y; Liu C; Zhu Q; Huang X; Li H; Yang R
Epigenetics; 2024 Dec; 19(1):2352683. PubMed ID: 38723244
[TBL] [Abstract] [Full Text] [Related]
8. Methyl CpG binding protein MBD2 has a regulatory role on the BRCA1 gene expression and its modulation by resveratrol in ER+, PR+ & triple-negative breast cancer cells.
Sahu RK; Tandon S; Singh S; Das BC; Hedau ST
BMC Cancer; 2024 May; 24(1):566. PubMed ID: 38711004
[TBL] [Abstract] [Full Text] [Related]
9. [Efficacy analysis of chemotherapy and endocrine therapy combined with targeted drugs after progression on cyclin-dependent kinase 4/6 inhibitor treatment in hormone receptor positive/human epidermal growth factor receptor 2-low metastatic breast cancer].
Liu B; Yuan Y; Li F; Li JB; Bian L; Wang T; Zhang SH; Jiang ZF
Zhonghua Yi Xue Za Zhi; 2024 May; 104(17):1507-1513. PubMed ID: 38706058
[No Abstract] [Full Text] [Related]
10. Atypical memory B cells increase in the peripheral blood of patients with breast cancer regardless of lymph node involvement.
Azizi A; Mehdipour F; Samadi M; Rasolmali R; Talei AR; Ghaderi A
BMC Immunol; 2024 May; 25(1):25. PubMed ID: 38702630
[TBL] [Abstract] [Full Text] [Related]
11. Association between pathological characteristics and recurrence score by OncotypeDX in resected T1-3 and N0-1 breast cancer: a real-life experience of a North Hungarian regional center.
Deme D; Tamaskovics BF; Jammoul N; Kovács S; Kayode EO; Grice JW; Telekes A
Pathol Oncol Res; 2024; 30():1611735. PubMed ID: 38689824
[No Abstract] [Full Text] [Related]
12. The evolvement of breast cancer therapies: What we have done and where all these head off.
Nurlaila I; Pambudi S
Saudi Med J; 2024 Apr; 45(4):331-340. PubMed ID: 38657992
[TBL] [Abstract] [Full Text] [Related]
13. Mutant RAS-driven Secretome Causes Skeletal Muscle Defects in breast cancer.
Wang R; Khatpe AS; Kumar B; Mang HE; Batic K; Adebayo AK; Nakshatri H
Cancer Res Commun; 2024 May; 4(5):1282-1295. PubMed ID: 38651826
[TBL] [Abstract] [Full Text] [Related]
14. [Not Available].
Lokøy IK; Bakken IS; Wik E; Stefansson IM
Tidsskr Nor Laegeforen; 2024 Apr; 144(5):. PubMed ID: 38651722
[TBL] [Abstract] [Full Text] [Related]
15. TRPS1 is a Highly Sensitive Marker for breast cancer: A Tissue Microarray Study Evaluating More Than 19,000 Tumors From 152 Different Tumor Entities.
Lennartz M; Löhr N; Höflmayer D; Dwertmann Rico S; von Bargen C; Kind S; Reiswich V; Viehweger F; Lutz F; Bertram V; Fraune C; Gorbokon N; Weidemann S; Blessin NC; Hube-Magg C; Menz A; Schlichter R; Krech T; Hinsch A; Burandt E; Sauter G; Simon R; Kluth M; Marx AH; Lebok P; Dum D; Minner S; Jacobsen F; Clauditz TS; Bernreuther C; Steurer S
Am J Surg Pathol; 2024 Jun; 48(6):637-651. PubMed ID: 38647255
[TBL] [Abstract] [Full Text] [Related]
16. [Case Report of Occult breast cancer with Triple Negative Subtype].
Tanaka Y; Ohshima Y; Fukaya Y; Hosoya K; Wakahara M
Gan To Kagaku Ryoho; 2024 Apr; 51(4):421-423. PubMed ID: 38644310
[TBL] [Abstract] [Full Text] [Related]
17. Log odds of positive lymph nodes (LODDS)-based novel nomogram for survival estimation in patients with invasive micropapillary carcinoma of the breast.
Meng X; Hao F; Wang N; Qin P; Ju Z; Sun D
BMC Med Res Methodol; 2024 Apr; 24(1):90. PubMed ID: 38637725
[TBL] [Abstract] [Full Text] [Related]
18. Bifunctional HDAC and DNMT inhibitor induces viral mimicry activates the innate immune response in triple-negative breast cancer.
Fan W; Li W; Li L; Qin M; Mao C; Yuan Z; Wang P; Chu B; Jiang Y
Eur J Pharm Sci; 2024 Jun; 197():106767. PubMed ID: 38636781
[TBL] [Abstract] [Full Text] [Related]
19. breast cryoablation for the palliative treatment of indolent subtype of multicentric triple-negative breast cancer.
Huang ML; Lane DL; Bomar H; Kuerer H
BMJ Case Rep; 2024 Apr; 17(4):. PubMed ID: 38627044
[TBL] [Abstract] [Full Text] [Related]
20. The Relationship between breast cancer Subtypes, Prognostic Factors, and Apparent Diffusion Coefficient Histogram Analysis.
Aktas E; Uylar Seber T; Seber T; Burcek NV; Akay E; Arslan A; Karagöz Eren S; Ozhan N; Yaltırık Bilgin E; Savran B; Akdur P
Curr Med Imaging; 2024; 20(1):e15734056271069. PubMed ID: 38616751
[TBL] [Abstract] [Full Text] [Related]
[Next]
